Feb 17 (Reuters) - Polaryx Therapeutics Inc PLYX.O:
POLARYX THERAPEUTICS SELECTS CONTRACT RESEARCH ORGANIZATION FOR SOTERIA PHASE 2 BASKET TRIAL
POLARYX THERAPEUTICS INC: CONTINUES TO ACTIVELY WORK WITH ITS CONTRACT RESEARCH ORGANIZATION (CRO) TO INITIATE TRIAL IN FIRST HALF OF 2026
Source text: ID:nGNE9RWxdW
Further company coverage: PLYX.O
((Reuters.Briefs@thomsonreuters.com;))